4 results
Comparison of the additional blood pressure lowering effect of RFSD with that of the addition of spironolactone in patients with a persistant increased blood pressure despite treatment with three different antihypertensive agents.
Main objective: To investigate whether spironolactone can favourably alter extra-cellular matrix remodelling, assessed by changes in the fibrosis biomarker Procollagen Type III N-Terminal Peptide (PIIINP), in patients at increased risk of developing…
To obtain user and medical staff feed-back on the safety, clinical performance and ergonomic features of the IPS and IBO.
Study the effectiveness and safety of LAAO in non-valvular AF patients at high stroke risk unable to use OAC